Omkar Speciality Chemicals has received an approval to enter into memorandum of understanding (MOU) with LASA Laboratory for acquisition of the company’s shares along with assets. The board at its meeting held on March 07, 2012 has approved for the same.
Further, the board has authorized the managing director of the company to carry on the above mentioned transaction.
Omkar Speciality Chemicals is mainly engaged in the manufacture and sale of speciality chemicals viz., selenium compounds, iodine compounds, molybdenum compounds etc. and pharma intermediates viz., Potassium Iodate, Bismuth Ammonium Citrate, Bromoform etc.
